TNF-α induces thromboxane receptor signaling-dependent microcirculatory dysfunction in mouse liver

Shock

Volumn 30, Issue 4, 2008, Pages 463-467

  Katagiri, Hiroyuki ^a   Ito, Yoshiya ^a   Ito, Sohei ^a   Murata, Takahiko ^b   Sugimoto, Yukihiko ^b   Narumiya, Shuh ^b   Watanabe, Masahiko ^a   Majima, Masataka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Endothelial cell; Endotoxemia; Leukocyte; Sinusoid; TNF

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; ALANINE AMINOTRANSFERASE; LIPOPOLYSACCHARIDE; OZAGREL; THROMBOXANE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENDOTOXEMIA; FLUORESCENCE MICROSCOPY; IN VIVO STUDY; LEUKOCYTE; MALE; MICROANGIOPATHY; MOUSE; NONHUMAN;

ANIMALS; CELL ADHESION; LEUKOCYTES; LIVER; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROCIRCULATION; RECEPTORS, THROMBOXANE; RECOMBINANT PROTEINS; SEPSIS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 54049158457     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181673f54     Document Type: Article

References (33)

1. McCuskey RS: Hepatic microvascular response to endotoxemia and sepsis. Prog Appl Microcirc 19:76-84, 1993.
2. Vollmar B, Rüttinger D, Wanner GA, Leiderer R, Menger MD: Modulation of Kupffer cell activity by gadolinium chloride in endotoxemic rats. Shock 6:434-441, 1996.
3. Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL: In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am J Pathol 138(2):395-402, 1991.
4. Luster MI, Germolec DR, Yoshida T, Kayama F, Thompson M: Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 19(2):480-488, 1994.
5. Essani NA, Fisher MA, Farhood A, Manning AM, Smith CW, Jaeschke H: Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology 21(6):1632-1639, 1995.
6. Matsumoto Y, Ito Y, Hayashi I, Majima M, Ishii K, Katagiri H, Kakita A: Effect of FR167653, a novel inhibitor of tumor necrosis factor alpha and interleukin-1 beta synthesis on lipopolysaccharide-induced hepatic microvascular dysfunction in mice. Shock 17(5):411-415, 2002.
7. Fox-Robichaud A, Kubes P: Molecular mechanisms of tumor necrosis factor-stimulated leukocyte recruitment into the murine hepatic circulation. Hepatology 31(5):1123-1127, 2000.
8. Klintman D, Schramm R, Menger MD, Thorlacius H: Leukocyte recruitment in hepatic injury: selectin-mediated leukocyte rolling is a prerequisite for CD18-dependent firm adhesion. J Hepatol 36(1):53-59, 2002.
9. Ishii K, Ito Y, Katagiri H, Matsumoto Y, Kakita A, Majima M: Neutrophil elastase inhibitor attenuates lipopolysaccharide-induced hepatic microvascular dysfunction in mice. Shock 18(2):163-168, 2002.
10. Katagiri H, Ito Y, Ishii K, Hayashi I, Suematsu M, Yamashina S, Murata T, Narumiya S, Kakita A, Majima M: Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice. Hepatology 39(1):139-150, 2004.
11. Yokoyama Y, Nimura Y, Nagino M, Bland KI, Chaudry IH: Role of thromboxane in producing hepatic injury during hepatic stress. Arch Surg 140(8):801-807, 2005.
12. Ito S, Ito Y, Katagiri H, Suzuki T, Hoka S, Yokomizo T, Shimizu T, Majima M: Leukotriene B4/BLT1 pathway is involved in hepatic microcirculatory dysfunction elicited by endotoxin. Shock 30:87-91, 2008.
13. 2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats. Am J Physiol Gastrointest Liver Physiol 288(2):G277-G283, 2005.
14. 2 receptor in hepatic sinusoidal endothelial cells and its role in endotoxin-induced liver injury in rats. Hepatology 20(5):1281-1286, 1994.
15. 2 receptor antagonist, inhibits tumor necrosis factor-a biosynthesis. Eur J Pharmacol 286(1):31-39, 1995.
16. Kuhn DC, Stauffer JL, Gaydos LJ, Lacey SL, Demers LM: An inhibitor of thromboxane production attenuates tumor necrosis factor release by activated human alveolar macrophages. Prostaglandins 46(3):195-205, 1993.
17. Grandel U, Fink L, Blum A, Heep M, Buerke M, Kraemer HJ, Mayer K, Bohle RM, Seeger W, Grimminger F, et al.: Endotoxin-induced myocardial tumor necrosis factor-a synthesis depresses contractility of isolated rat hearts. Evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation 102(22):2758-2764, 2000.
18. 2 and prostaglandin F2 alpha mediate inflammatory tachycardia. Nat Med 11(5):562-566, 2005.
19. Watanabe H, Katoh T, Eiro M, Iwamoto M, Ushikubi F, Narumiya S, Watanabe T: Effects of salt loading on blood pressure in mice lacking the prostanoid receptor gene. Circ J 69(1):124-126, 2005.
20. Kobayashi T, Tahara Y, Matsumoto M, Iguchi M, Sano H, Murayama T, Arai H, Oida H, Yurugi-Kobayashi T, Yamashita JK, et al.: Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest 114(6):784-794, 2004.
21. Ichikawa K, Tazawa S, Hamano S, Kojima M, Hiraku S: Effect of ozagrel on locomotor and motor coordination after transient cerebral ischemia in experimental animal models. Pharmacology 59(5):257-265, 1999.
22. Yamamoto N, Sakai F, Yamazaki H, Nakahara K, Okuhara K: Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. Eur J Pharmacol 314(1-2):137-142, 1996.
23. Yamamoto N, Sakai F, Yamazaki H, Sato N, Nakahara K, Okuhara K: FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-[alpha], ameliorates endotoxin-induced shock. Eur J Pharmacol 327(2-3): 169-175, 1997.
24. Ohtani Y, Takeyoshi I, Koibuchi Y, Matsumoto K, Muramoto M, Morishita Y: The effect of FR167653 on pulmonary ischemia-reperfusion injury in rats. J Heart Lung Transplant 19(4):377-383, 2000.
25. Decker K: Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 192(2):245-361, 1990.
26. Lee JC, Laydon JT, McDonnel PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heyes JR, Landvatter SW, et al.: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 (6508):739-746, 1994.
27. 2 in early BDL-induced portal hypertension. Am J Physiol Gastrointest Liver Physiol 284(3): G453-G460, 2003.
28. Narumiya S, FitzGerald GA: Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108(1):25-30, 2001.
29. Fennekohl A, Schieferdecker HL, Jungermann K, Puschel GP: Differential expression of prostanoid receptors in hepatocytes, Kupffer cells, sinusoidal endothelial cells and stellate cells of rat liver. J Hepatol 30(1):38-47, 1999.
30. 2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells. Eur J Pharmacol 312(3):367-377, 1996.
31. Chen G, Wilson R, McKillop JH, Walker JJ: The role of cytokines in the production of prostacyclin and thromboxane in human mononuclear cells. Immunol Invest 23(4-5):269-279, 1994.
32. 2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells. Clin Exp Immunol 112(3):464-470, 1998.
33. Marshall JC, Deitch E, Moldawer LL, Opal S, Redl H, van der Poll T: Preclinical models of shock and sepsis: what can they tell us? Shock 24:1-6, 2005.